HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Clinical studies of efficacy of piperacillin against complicated urinary tract infections].

Abstract
Clinical efficacy of piperacillin against 74 cases with complicated urinary tract infection was examined. Piperacillin was administered at the dose of 4 g (2 g twice daily) through intravenous drip infusion. The overall clinical value was rated in "excellent", in 9 cases, "moderate" in 34 cases and "poor" in 31 cases with a total efficacy of 58.1%. In the analysis of clinical values based on background, its efficacy was statistically significantly lower in the patients at a higher age, those with complication of diabetes mellitus, and those with indwelling catheter. In operated cases compared to non-operated cases, it was suggested to be more effective for improving the disturbances in urinary flow as a result of the removal of the underlying conditions by the operation. As to bacteriological efficacy, 64 out of 95 strains (67.4%) isolated were eradicated following its administration. Microbes which appeared after its dosing belonged to 9 classes of 18 strains, of which 5 strains (27.8%) of Serratia were identified. Side effects were 2.5% (3/119), no serious cases appeared. Changes in laboratory examination results were elevated GOT (2.5%), GPT (1.7%), and ALP (0.8%) values, all being transient hanges.
AuthorsT Ikeuchi, S Yogi, M Ueno, F Morikawa, Y Onodera, M Sakamoto, Y Kai
JournalHinyokika kiyo. Acta urologica Japonica (Hinyokika Kiyo) Vol. 32 Issue 1 Pg. 143-50 (Jan 1986) ISSN: 0018-1994 [Print] JAPAN
PMID3962805 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Piperacillin
Topics
  • Adult
  • Aged
  • Catheters, Indwelling (adverse effects)
  • Diabetes Complications
  • Female
  • Humans
  • Male
  • Middle Aged
  • Piperacillin (adverse effects, therapeutic use)
  • Urinary Tract Infections (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD